Pérez Alati, Grondona, Benites & Arntsen, Norton Rose Fulbright, Gómez-Pinzón, VVS Abogados, BurgherGray, Vásquez Villarreal Consultores S.A.S. and Rivera Bolívar y Castañedas advised on the deal
Darby Private Equity (“Darby”), a private equity arm of Franklin Templeton, today announced that Darby Latin American Private Debt Fund III, L.P. (“DLAPDF III”) completed an investment in Pharma Consulting Group, S.A. (known as “Biopas”), a specialty pharmaceutical distribution company focused on in-licensing, selling and marketing innovative prescription pharmaceutical products, cosmetics and medical devices. Transaction details were not disclosed.
Since Biopas was founded in 2002, it has expanded into 13 Latin American countries. The company’s primary market is Colombia, and it also has a strong presence in Peru, Ecuador, Chile and Argentina. Biopas is headquartered in Panama and operates in five main business units: Immunology, Rare Diseases, Central Nervous Systems and Oncology, Specialty Care, and Dermatology.
The investment in Biopas adds to Darby’s long history of successful investments in Latin America. Darby has played a pioneering role in bringing private equity and private debt investments to emerging market regions.
In Argentina, Pérez Alati, Grondona, Benites & Arntsen advised Darby with a team including Alan Arntsen (Picture), Valeria Stemkauskas, María Lourdes Arias, Cristian Chang and Paula Balbi.
In New York Norton Rose Fulbright advised Darby with Tracy Horton.
In Colombia, Gómez-Pinzón Abogados advised Darby with Ricardo Fandiño De La Calle, Jimena Alarcón and Ana María Herrera.
In Panama, SIGMA International and Global Market Attorneys
advised Darby with Cecilio Castillero.
In Argentina VVS Abogados advised Pharma Consulting Group S.A. with Jorge Vallejos and Ariel Rusconi
In US, BurgherGray advised Pharma Consulting Group S.A. with Gopal Burgher and Brian Idehen
In Colombia Vásquez Villarreal Consultores advised Pharma Consulting Group S.A. with Alfredo Vazquez
In Panama, Rivera Bolívar y Castañedas advised Pharma Consulting Group S.A. with a team led by Irene Itzel Bolívar Cisneros
Involved fees earner: Gopal Burgher – BurgherGray; Brian Idehen – BurgherGray; Ricardo Fandiño De La Calle – Gómez-Pinzón; Jimena González Alarcón – Gómez-Pinzón; Tracy Louise Horton – Norton Rose Fulbright; María Lourdes Arias – Pérez Alati, Grondona, Benites & Arntsen; Alan Arntsen – Pérez Alati, Grondona, Benites & Arntsen; Paula Balbi – Pérez Alati, Grondona, Benites & Arntsen; Cristian Marcos Chang – Pérez Alati, Grondona, Benites & Arntsen; Valeria Stemkauskas – Pérez Alati, Grondona, Benites & Arntsen; Irene Itzel Bolívar Cisneros – Rivera Bolívar y Castañedas; Cecilio Castillero – SIGMA Abogados; Jorge Vallejos – VVS Abogados;